Clinical TrialsSearch results
Number of results: 510
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Other
- A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with Hypertension
- Atrial Fibrillation with Hypertension
- The J-RHYTHM II Investigators
- 2006-07-10
Other
- A randomized trial of lamivudine continuous therapy and entecavir switching therapy for chronic hepatitis B patients treated with lamivudine monotherapy
- Chronic hepatitis B
- Nagoya City University Hospital
- 2008-04-16
Other
- A Randomized, Double-Blind, Phase III Study Comparing Investigational Drug HBI-8000 Combined With Nivolumab vs. Placebo with Nivolumab in Patients With Advanced Melanoma
- Unresectable or Metastatic Melanoma
- Onogi Hiroshi
- 2023-03-27
Other
- A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-03-16
Other
- A retrospective analysis of the association between histological lesion and renal outcome in patients with lupus nephritis
- lupus nephritis
- The Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2009-05-18
Other
- A retrospective study on aphasia therapy
- Cerebrovascular disease Traumatic brain injury
- Japan Society for Higher Brain Dysfunction
- 2009-07-15
Other
- A Study of JNJ-64407564 in Japanese Participants with Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Fujikawa Ei
- 2021-04-01
Other
- A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma (iinnovate-1)
- Multiple Myeloma
- Asato Takayuki
- 2022-12-26
Other
- A study of Teclistamab in Japanese Participants with Relapsed or Refractory Multiple Myeloma
- Hematologic Malignancies
- Nishikawa Kazuko
- 2021-01-29